Maternal care for anti-D [Rh] antibodies, third trimester (fetus 4)
ICD-10 O36.0134 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies, third trimester (fetus 4).
O36.0134 refers to maternal care for a pregnant woman who has developed anti-D (Rh) antibodies during her pregnancy, specifically in the third trimester, and is carrying her fourth fetus. This condition is critical as it can lead to hemolytic disease of the fetus and newborn (HDFN), which can cause fetal anemia, jaundice, and even heart failure if not monitored and managed appropriately. The presence of anti-D antibodies indicates that the mother has been sensitized to Rh-positive blood, which can cross the placenta and affect the fetus. Careful monitoring of the fetus's growth, well-being, and potential distress is essential. This includes regular ultrasounds to assess fetal growth and amniotic fluid levels, as well as non-stress tests (NST) to evaluate fetal heart rate patterns. The management may involve interventions such as intrauterine transfusions if severe anemia is detected, and planning for delivery in a controlled environment to ensure immediate care for the newborn if necessary.
Detailed records of maternal antibody testing, fetal monitoring, and any interventions performed.
Management of a pregnant woman with a history of Rh sensitization, monitoring for fetal anemia, and planning for delivery.
Ensure accurate coding for multiple fetuses and potential complications arising from Rh incompatibility.
Comprehensive documentation of high-risk assessments, including ultrasound findings and fetal well-being evaluations.
Complex cases involving intrauterine transfusions or advanced monitoring techniques for fetuses affected by maternal antibodies.
Focus on the multidisciplinary approach to care and the need for precise coding of interventions.
Used for monitoring fetal growth and well-being in patients with anti-D antibodies.
Document the reason for the ultrasound and findings related to fetal health.
Obstetricians should ensure that the ultrasound findings are clearly linked to the maternal condition.
Anti-D antibodies can lead to serious complications in pregnancy, including hemolytic disease of the newborn. Monitoring and management are crucial to ensure the health of both the mother and fetus.
